Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001615219-25-000053
Filing Date
2025-05-15
Accepted
2025-05-15 17:18:30
Documents
3
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A slrx-2025proxystatementupd.htm PRE 14A 232962
2 screenshot2025-05x15101804.jpg GRAPHIC 155645
3 screenshot2025-05x15101847.jpg GRAPHIC 233708
  Complete submission text file 0001615219-25-000053.txt   770688
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36812 | Film No.: 25955814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)